Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay

Alexius Freyberger1, Gabriele Schmuck

  • 1BAYER HealthCare AG, PH PD P Toxicology, D-42096 Wuppertal, Germany. alexius.freyberger@bayerhealthcare.com

Toxicology Letters
|December 9, 2004
PubMed

Related Concept Videos